| 000 | 01168 a2200313 4500 | ||
|---|---|---|---|
| 005 | 20250513072929.0 | ||
| 264 | 0 | _c19930818 | |
| 008 | 199308s 0 0 eng d | ||
| 022 | _a0163-4356 | ||
| 024 | 7 |
_a10.1097/00007691-199306000-00006 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aColbert, D L | |
| 245 | 0 | 0 |
_aExperience with cost-effective in-house reagents for the assay of carbamazepine in serum, using the Abbott TDx. _h[electronic resource] |
| 260 |
_bTherapeutic drug monitoring _cJun 1993 |
||
| 300 |
_a209-12 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 |
_aCarbamazepine _xblood |
| 650 | 0 | 4 |
_aChemistry, Clinical _xeconomics |
| 650 | 0 | 4 |
_aChromatography, High Pressure Liquid _xmethods |
| 650 | 0 | 4 | _aCost-Benefit Analysis |
| 650 | 0 | 4 | _aCross Reactions |
| 650 | 0 | 4 | _aDrug Stability |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aQuality Control |
| 650 | 0 | 4 |
_aReagent Kits, Diagnostic _xeconomics |
| 700 | 1 | _aTurner, G J | |
| 773 | 0 |
_tTherapeutic drug monitoring _gvol. 15 _gno. 3 _gp. 209-12 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/00007691-199306000-00006 _zAvailable from publisher's website |
| 999 |
_c8332279 _d8332279 |
||